September 5, 2012
Daikichiro Kobayashi, Associate General Manager, Sales Division Meiji Seika Pharma aims to bolster its presence in the field of internal medicine by leveraging its chronic obstructive pulmonary disease (COPD) treatment Oxis (formoterol), which was launched on September 3. Many patients...read more